Pharmaceutical R&D Developer
DARMSTADT, Germany, March 3, 2020 /PRNewswire/ -- Leading science and technology company Merck today launched the company'sLANEXO™ Laboratory Inventory, Safety, and Compliance Management System, this new digital laboratory informatics solution is designed to significantly reduce the time [1] spent in the laboratory, as well as substantially enhance data quality and traceability.
Jean-Charles Voth, Head of Application Solutions at Merck Life ScienceJean-Charles Wirth) stated: “Currently, 85% of laboratories use paper or Excel to manage consumables data, spending 25% of their time on these administrative tasks, which prevents scientists from focusing on their benchwork. Laboratory efficiency is critical, as it affords scientists more time to concentrate on research and analysis while reducing time spent on administrative duties, ultimately helping to accelerate drug development. Our LANEXO™ system boasts best-in-class features, underscoring Merck’s commitment to advancing and commercializing laboratory informatics.”
Laboratory informatics primarily focuses on the utilization of data, employing software, data management tools, and equipment platforms to support the capture and interpretation of scientific data for immediate use, and subsequently storing such data for future research and development. RecentResearch and Markets Global Market Outlook Reportstated that the market value of laboratory informatics reached $2.4 billion in 2018 and is projected to reach $5.45 billion by 2027.
Merck is the first company to offer radio-frequency identification (RFID) tags that can automatically register opening dates and calculate expiration dates. Leveraging such digital data capture, the LANEXO™ system can rapidly record laboratory reagent data in real time. Digital monitoring of inventory, expiration dates, and storage conditions reduces human error, lowers safety risks, and enhances the reliability and traceability of compliance documentation. Ultimately, all reagents, including those prepared in-house, can be immediately linked to a complete audit report. Within the laboratory workflow, the LANEXO™ system facilitates effortless reagent identity verification and provides automated alerts to help scientists avoid using expired reagents, thereby minimizing errors in experiments.
The cloud-based LANEXO™ system can be easily set up and rapidly integrated into existing laboratory workflows. The system includes mobile (Android) and web applications, designed for use in highly regulated analytical and research laboratories within the pharmaceutical, quality assurance/control, and industrial testing markets.
Merck launched last yearMilli-Q® Connect, this is a cloud-based service portal designed for Merck’s water purification systems. Last year, Merck also acquired BSSN Software, a laboratory informatics company that makes data more accessible to facilitate seamless integration, collaboration, analysis, and long-term archiving.
Merck inPittcon Conference & Expo 2020The LANEXO™ system was launched at a press conference during the 2020 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon), held in Chicago, Illinois, USA. This system represents an expansion of Merck’s portfolio of digital laboratory productivity solutions. For more information, please visitwww.SigmaAldrich.com/Lanexo。
All Merck press releases are distributed via email simultaneously with their publication on the Merck website. Please visitwww.merckgroup.com/subscribe, to register online, change options, or discontinue this service.